Atara Biotherapeutics, Inc. (ATRA)

NASDAQ: ATRA · IEX Real-Time Price · USD

11.01

+0.50 (4.81%)

At close: Jul 19, 2024, 4:00 PM

12.97

+1.96 (17.80%)

Pre-market: Jul 22, 2024, 7:11 AM EDT

Atara Biotherapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2013
Revenue	34.7	8.57	63.57	20.34	0	0	Upgrade
Revenue Growth (YoY)	-39.63%	-86.51%	212.55%	-	-	-	Upgrade
Cost of Revenue	10.66	8.89	0	0	0	0	Upgrade
Gross Profit	24.05	-0.31	63.57	20.34	0	0	Upgrade
Selling, General & Admin	48.15	50.91	71.55	78.8	64.4	79.58	Upgrade
Research & Development	208.14	224.79	272.53	282	244.65	216.1	Upgrade
Operating Expenses	256.28	275.69	344.09	360.8	309.05	295.68	Upgrade
Operating Income	-232.24	-276.01	-280.51	-340.46	-309.05	-295.68	Upgrade
Interest Expense / Income	5.1	5.29	0.37	-0.37	-2.45	-4.72	Upgrade
Other Expense / Income	-4.25	-5.18	-52.6	-	-	-	Upgrade
Pretax Income	-233.09	-276.11	-228.29	-340.1	-306.61	-290.96	Upgrade
Income Tax	0.02	0.02	0.01	0.05	0.02	0.01	Upgrade
Net Income	-233.11	-276.13	-228.3	-340.14	-306.62	-290.98	Upgrade
Shares Outstanding (Basic)	6	4	4	4	3	2	Upgrade
Shares Outstanding (Diluted)	6	4	4	4	3	2	Upgrade
Shares Change	35.22%	3.85%	8.88%	26.63%	44.17%	17.11%	Upgrade
EPS (Basic)	-53.25	-65.25	-56.00	-90.75	-103.75	-141.75	Upgrade
EPS (Diluted)	-53.25	-65.25	-56.00	-90.75	-103.75	-141.75	Upgrade
Free Cash Flow	-185.09	-194.18	-179.86	-231.1	-185.27	-241.2	Upgrade
Free Cash Flow Per Share	-32.91	-45.83	-44.09	-61.68	-62.62	-117.53	Upgrade
Gross Margin	69.30%	-3.65%	100.00%	100.00%	-	-	Upgrade
Operating Margin	-669.19%	-3219.48%	-441.25%	-1673.85%	-	-	Upgrade
Profit Margin	-671.70%	-3220.88%	-359.12%	-1672.28%	-	-	Upgrade
Free Cash Flow Margin	-533.33%	-2264.96%	-282.92%	-1136.19%	-	-	Upgrade
EBITDA	-211.11	-254.2	-213.35	-329.17	-299.26	-287.65	Upgrade
EBITDA Margin	-608.32%	-2965.15%	-335.60%	-1618.33%	-	-	Upgrade
Depreciation & Amortization	16.88	16.62	14.57	11.29	9.79	8.03	Upgrade
EBIT	-227.99	-270.83	-227.92	-340.46	-309.05	-295.68	Upgrade
EBIT Margin	-656.95%	-3159.06%	-358.51%	-1673.85%	-	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).